These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 37734874)

  • 1. Association between biological immunotherapy for psoriasis and time to incident inflammatory arthritis: limitations and opportunities.
    Koehm M; Behrens F
    RMD Open; 2023 Sep; 9(3):. PubMed ID: 37734874
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biological disease-modifying antirheumatic drugs may mitigate the risk of psoriatic arthritis in patients with chronic plaque psoriasis.
    Gisondi P; Bellinato F; Targher G; Idolazzi L; Girolomoni G
    Ann Rheum Dis; 2022 Jan; 81(1):68-73. PubMed ID: 34144965
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical Burden of Concomitant Joint Disease in Psoriasis: A US-Linked Claims and Electronic Health Records Database Analysis.
    Skornicki M; Prince P; Suruki R; Lee E; Louder A
    Adv Ther; 2021 May; 38(5):2458-2471. PubMed ID: 33818686
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TNF alpha inhibitors in the treatment of psoriasis and psoriatic arthritis.
    Tobin AM; Kirby B
    BioDrugs; 2005; 19(1):47-57. PubMed ID: 15691217
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treating the skin with biologics in patients with psoriasis decreases the incidence of psoriatic arthritis.
    Acosta Felquer ML; LoGiudice L; Galimberti ML; Rosa J; Mazzuoccolo L; Soriano ER
    Ann Rheum Dis; 2022 Jan; 81(1):74-79. PubMed ID: 34281904
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative risk of serious infections among real-world users of biologics for psoriasis or psoriatic arthritis.
    Li X; Andersen KM; Chang HY; Curtis JR; Alexander GC
    Ann Rheum Dis; 2020 Feb; 79(2):285-291. PubMed ID: 31672774
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The risk of treated anxiety and treated depression among patients with psoriasis and psoriatic arthritis treated with apremilast compared to biologics, DMARDs and corticosteroids: a cohort study in the United States MarketScan database.
    Vasilakis-Scaramozza C; Persson R; Hagberg KW; Jick S
    J Eur Acad Dermatol Venereol; 2020 Aug; 34(8):1755-1763. PubMed ID: 31981426
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of tumour necrosis factor inhibitors, methotrexate, non-steroidal anti-inflammatory drugs and corticosteroids on cardiovascular events in rheumatoid arthritis, psoriasis and psoriatic arthritis: a systematic review and meta-analysis.
    Roubille C; Richer V; Starnino T; McCourt C; McFarlane A; Fleming P; Siu S; Kraft J; Lynde C; Pope J; Gulliver W; Keeling S; Dutz J; Bessette L; Bissonnette R; Haraoui B
    Ann Rheum Dis; 2015 Mar; 74(3):480-9. PubMed ID: 25561362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inflammatory dietary pattern and incident psoriasis, psoriatic arthritis, and atopic dermatitis in women: A cohort study.
    Bridgman AC; Qureshi AA; Li T; Tabung FK; Cho E; Drucker AM
    J Am Acad Dermatol; 2019 Jun; 80(6):1682-1690. PubMed ID: 30797850
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of guselkumab, a selective IL-23 inhibitor, in Preventing Arthritis in a Multicentre Psoriasis At-Risk cohort (PAMPA): protocol of a randomised, double-blind, placebo controlled multicentre trial.
    Haberman RH; MacFarlane KA; Catron S; Samuels J; Blank RB; Toprover M; Uddin Z; Hu J; Castillo R; Gong C; Qian K; Piguet V; Tausk F; Yeung J; Neimann AL; Gulliver W; Thiele RG; Merola JF; Ogdie A; Rahman P; Chakravarty SD; Eder L; Ritchlin CT; Scher JU
    BMJ Open; 2022 Dec; 12(12):e063650. PubMed ID: 36564123
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modifiable risk factors and the development of psoriatic arthritis in people with psoriasis.
    Green A; Shaddick G; Charlton R; Snowball J; Nightingale A; Smith C; Tillett W; McHugh N;
    Br J Dermatol; 2020 Mar; 182(3):714-720. PubMed ID: 31209855
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of psoriasis and psoriatic arthritis.
    Papoutsaki M; Costanzo A
    BioDrugs; 2013 Jan; 27 Suppl 1():3-12. PubMed ID: 23990277
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Managing patients with psoriatic disease: the diagnosis and pharmacologic treatment of psoriatic arthritis in patients with psoriasis.
    Mease PJ; Armstrong AW
    Drugs; 2014 Mar; 74(4):423-41. PubMed ID: 24566842
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Incidence and Risk Factors for Psoriatic Arthritis in Patients With Psoriasis: A Prospective Cohort Study.
    Eder L; Haddad A; Rosen CF; Lee KA; Chandran V; Cook R; Gladman DD
    Arthritis Rheumatol; 2016 Apr; 68(4):915-23. PubMed ID: 26555117
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term Persistence of First-line Biologics for Patients With Psoriasis and Psoriatic Arthritis in the French Health Insurance Database.
    Pina Vegas L; Penso L; Claudepierre P; Sbidian E
    JAMA Dermatol; 2022 May; 158(5):513-522. PubMed ID: 35319735
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk of cancer, tuberculosis and serious infections in patients with ankylosing spondylitis, psoriatic arthritis and psoriasis treated with IL-17 and TNF-α inhibitors: a nationwide nested case-control analysis.
    Kim HW; Kim EH; Lee M; Jung I; Ahn SS
    Clin Exp Rheumatol; 2023 Jul; 41(7):1491-1499. PubMed ID: 36533975
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endothelial dysfunction and the effects of TNF inhibitors on the endothelium in psoriasis and psoriatic arthritis: a systematic review.
    Brezinski EA; Follansbee MR; Armstrong EJ; Armstrong AW
    Curr Pharm Des; 2014; 20(4):513-28. PubMed ID: 23565632
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeted therapies: what they teach us about the pathogenesis of psoriasis and psoriatic arthritis.
    Tan WS; Kelly S; Pitzalis C
    Expert Rev Clin Immunol; 2017 Mar; 13(3):207-222. PubMed ID: 27690678
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of Musculoskeletal Symptoms in Patients with Psoriasis and Predictors Associated with the Development of Psoriatic Arthritis: Retrospective Analysis of a US Claims Database.
    Merola JF; Patil D; Egana A; Steffens A; Webb NS; Gottlieb AB
    Dermatol Ther (Heidelb); 2023 Nov; 13(11):2635-2648. PubMed ID: 37726542
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Psoriatic arthritis onset in psoriatic patients receiving UV phototherapy in Italy.
    Balato A; Caiazzo G; Balato N; Napolitano M;
    G Ital Dermatol Venereol; 2020 Dec; 155(6):733-738. PubMed ID: 30251803
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.